Unexpected differences in early thyroidal trapping of iodide and pertechnetate

Area of Science:

• Nuclear medicine
• Thyroid physiology
• Pharmacokinetics

Background:

• Thyroid uptake of radioactive iodide (I-) and pertechnetate (TcO4-) is crucial for diagnosing and managing thyroid disorders.
• Previous studies have utilized compartmental analysis to understand thyroid tracer kinetics, but often without accounting for instantaneous uptake phases or arteriovenous differences.
• Antithyroid drug therapy significantly impacts thyroid function, necessitating precise methods to evaluate tracer handling during treatment.

Purpose of the Study:

• To apply compartmental analysis to simultaneously acquired 132I-iodide and 99mTc-pertechnetate thyroid uptake data.
• To investigate the 'instantaneous' phase of thyroid uptake and its behavior in thyrotoxic patients before and during antithyroid drug therapy.
• To compare the uptake characteristics of I- and TcO4- under varying therapeutic conditions.

Main Methods:

• Simultaneous acquisition of thyroid uptake data for 132I-iodide and 99mTc-pertechnetate.
• Application of compartmental analysis, incorporating arteriovenous plasma tracer differences and an 'instantaneous' uptake phase.
• Observation of four thyrotoxic patients, with measurements taken before and during antithyroid drug treatment.

Main Results:

• A greater 'instantaneous' uptake phase was observed for TcO4- compared to I-.
• The 'instantaneous' uptake of both I- and TcO4- demonstrated a potential increase during the initial six months of antithyroid drug therapy.
• Unidirectional clearance estimates were higher for I- and showed minimal variation early in therapy, failing to explain the observed uptake changes.

Conclusions:

• Compartmental analysis reveals distinct 'instantaneous' uptake characteristics for I- and TcO4- in thyrotoxicosis.
• Antithyroid drug therapy may modulate the 'instantaneous' thyroidal handling of both tracers over time.
• The findings suggest that factors beyond unidirectional clearance influence tracer uptake dynamics during early treatment.